Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.10.0.1
Stockholders' Equity
6 Months Ended
Jun. 30, 2018
Stockholders' Equity [Abstract]  
Stockholders' Equity

Note 8 - Stockholders’ Equity

 

Stock Options

 

The Company has an incentive stock plan, the Amended and Restated 2011 Equity Incentive Plan (the “2011 Plan”), and has granted stock options to employees, non-employee directors and consultants from the 2011 Plan. Options granted under the 2011 Plan may be Incentive Stock Options or Non-statutory Stock Options, as determined by the Administrator at the time of grant. On June 19, 2018, the Company’s stockholders approved an amendment to the 2011 Plan to increase the number of shares authorized for issuance under the 2011 Plan to a total of 10,000,000. As of June 30, 2018, there were 3,453,712 shares remaining available for issuance under the 2011 Plan.

 

During the six months ended June 30, 2018, the Company granted stock options to employees and non-employee directors to purchase a total of 758,000 shares of the Company’s common stock with grant date prices that ranged between $5.30 to $8.86 per share. The stock options have terms of ten years and are subject to vesting based on continuous service of the awardee over the periods ranging between zero and four years. The stock options have an aggregate grant date fair value of $3,031,676.

 

During the six months ended June 30, 2018, stock options for the purchase of 526,683 shares were exercised for cash proceeds of $389,158.

 

The Company recorded stock-based compensation as follows:

 

    For the Three Months Ended
June 30,
    For the Six Months Ended
June 30,
 
    2018     2017     2018     2017  
Research and development   $ 337,730     $ 76,267     $ 1,111,389     $ 142,960  
General and administrative     470,740       122,184       675,789       470,004  
Total   $ 808,470     $ 198,451     $ 1,787,178     $ 612,964  

 

The following table represents stock option activity for the six months ended June 30, 2018:

 

                Weighted Average        
    Stock Options     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – December 31, 2017     5,691,414       3,124,941     $ 1.16     $ 0.73     $ 0.73       6.87     $ -  
Granted     758,000       -       -       -       -       -       -  
Exercised     (526,683 )     -       -       -       -       -       -  
Cancelled     (36,459 )     -       -       -       -       -       -  
Balance – June 30, 2018     5,886,272       3,169,680     $ 1.98     $ 0.95     $ 0.95       6.71     $ 23,595,541  

 

The following table summarizes information on stock options outstanding and exercisable as of June 30, 2018:

 

            Weighted   Weighted        
Exercise     Number     Average Remaining   Average     Number  
Price     Outstanding     Contractual Term   Exercise Price     Exercisable  
                         
$ 0.05       52,876     3.76 years   $ 0.05       52,876  
$ 0.26       915,497     5.78 years   $ 0.26       915,497  
$ 0.73       1,131,691     6.38 years   $ 0.73       927,410  
$ 1.00       237,124     7.06 years   $ 1.00       170,458  
$ 1.10       8,000     7.53 years   $ 1.10       4,459  
$ 1.17       22,772     7.37 years   $ 1.17       2,147  
$ 1.22       70,312     7.60 years   $ 1.22       20,833  
$ 1.50       28,000     7.67 years   $ 1.50       11,333  
$ 1.55       1,456,000     7.69 years   $ 1.55       636,750  
$ 2.02       85,000     9.11 years   $ 2.02       46,250  
$ 2.40       926,000     8.59 years   $ 2.40       152,083  
$ 4.60       200,000     9.44 years   $ 4.60       25,000  
$ 5.30       275,000     9.74 years   $ 5.30       103,021  
$ 6.04       278,000     9.89 years   $ 6.04       101,563  
$ 8.86       200,000     8.94 years   $ 8.86       -  
  Totals       5,886,272                   3,169,680  

 

Warrants

 

During the six months ended June 30, 2018, warrants to purchase 274,315 shares of the Company’s common stock were exercised for aggregate cash proceeds of $591,990.

 

                Weighted Average        
    Warrants     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – December 31, 2017     4,533,020       4,517,395     $ 1.85     $ 1.85     $ 1.00       3.21     $ -  
Granted     780,500       -       -       -       -       -       -  
Exercised     (274,315 )     -       -       -       -       -       -  
Cancelled     -       -       -       -       -       -       -  
Balance – June 30, 2018     5,039,205       5,039,205     $ 2.37     $ 2.37     $ 1.18       2.74     $ 24,057,541